Literature DB >> 4036269

Mass vaccination programme aimed at eradicating measles, mumps and rubella in Sweden: vaccination of schoolchildren.

M Böttiger, B Christenson, J Taranger, M Bergman.   

Abstract

In 1982-83, a unique, two-dose programme of immunization with a combined vaccine against measles, mumps and rubella was initiated in Sweden. The first dose was administered at 18 months and the second at 12 years of age. A vaccination study was carried out on 247 12 year old schoolchildren from four schools situated in two urban and two rural areas. In urban areas, 30% of children were found to be susceptible to rubella and 18% to mumps, compared with 55% susceptible to rubella and 31% to mumps in rural areas. The reverse was found for measles, to which 20% of children lacked immunity in urban areas but only 6% in rural areas. Seroconversion was seen in 82% against measles, in 80% against mumps and in 100% against rubella. Follow-up studies of the timing and the virus dosage are also to be carried out.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4036269     DOI: 10.1016/0264-410x(85)90059-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Rubella in Europe.

Authors:  A Galazka
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.

Authors:  Jeremy Mauldin; Kathryn Carbone; Henry Hsu; Robert Yolken; Steven Rubin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 3.  Measles, mumps and rubella vaccine, autism and inflammatory bowel disease: advising concerned parents.

Authors:  David A C Elliman; Helen E Bedford
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.

Authors:  M Böttiger; B Christenson; V Romanus; J Taranger; A Strandell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.